Our proprietary GPCR-based drug discovery technologies are at the core of our research programs, enabling us to internally discover drug candidates. In addition to drug candidates currently in development, we have maintained an extensive research effort across several therapeutic areas with large market opportunities.

(This page was last updated: June 5, 2008. Additional information regarding Arena is available in its SEC filings.)